Skip to main content

ABOUT THIS WEBSITE

This website is intended to provide guidance for eye-care practitioners in the management of myopia in clinical practice. Those who developed this guidance recognize that research is continually evolving, and thus the content provided herein has been informed by currently available scientific research and may be reviewed and updated periodically. Care has been taken to ensure the information provided is balanced and objective to enable practitioners to manage their patients holistically.The information on this website comes in large part from our print brochure, Managing Myopia: A Clinical Response to the Growing Epidemic. It was created in collaboration with the authors listed below and is endorsed by the following organizations: American Optometric Association, Singapore Optometric Association, American Academy of Optometry, and Johnson & Johnson Vision.

ABOUT THIS WEBSITE image

Young Asian child playing outdoors.

AUTHORS OF MANAGING MYOPIA: A CLINICAL RESPONSE TO THE GROWING EPIDEMIC, THE PRINT BROCHURE WHICH INFORMS THIS WEBSITE, INCLUDE:

  • Alex Nixon, OD, MS, FAAO
  • Noel Brennan, PhD, MScOptom, FAAO
  • Contributors
  • David Berntsen, OD, PhD, FAAO
  • Kamlesh Chauhan, PhD, MCOptom
  • Xu Cheng, MD, PhD, FAAO, MBA
  • David Chong, D Optom, BSc Optom, MSc Clinical Optom
  • Lori Grover, OD, PhD
  • Koh Liang Hwee, BSc Optom (Hons) UK, PhD
  • Chui Wen Juan, B Optom Hons, M Optom, PGCOT
  • Chew Wai Kwong, BSc MCOptom UK
  • Michael Mayers, OD, FAAO
  • Jerry Neidigh, OD
  • Erin Nilon, BS, MBA
  • Andrew Pucker, OD, PhD, FAAO, FSLS, appointed by ASCO
  • Kathryn Richdale, OD, PhD, FAAO, appointed by ASCO
  • Tan Li Li, PhD, M MedSc (Optom), BOptom (Hons), FBCLA, FAAO
  • Ken Tong, Bsc Optom
  • Jeffrey Walline, OD, PhD
  • May Zhang, MD, PhD
  • Shirley Loh, B Optom, PGCOT

JOHNSON & JOHNSON VISION’S COMMITMENT TO EYE HEALTH

Johnson & Johnson Vision leads with science by generating new research and evidence. It is our intention to demonstrate thought leadership that will shape the future of myopia, changing the trajectory of this chronic and progressive disease.We believe it is essential to increase awareness of myopia as a disease which must be managed, and we will do so by empowering and activating eye-care practitioners through partnership, education, and advocacy.To that end, we are working tirelessly to build a comprehensive, novel portfolio of research, practice, and products that will help manage the progression of myopia.Join us. Together, we can take action on myopia.

Together, we can take action on myopia.